Researchers evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia -- higher than normal potassium levels. Hyperkalemia is a common electrolyte disorder which can cause potentially life-threatening cardiac arrhythmias and is associated with chronic kidney disease, heart failure, and diabetes mellitus.

Source: Drug lowers high potassium levels associated with potentially lethal cardiac arrhythmias


David Cottle

UBB Owner & Administrator